BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/25/2025 7:53:54 AM | Browse: 123 | Download: 566
 |
Received |
|
2024-08-21 05:38 |
|
Peer-Review Started |
|
2024-08-28 09:37 |
|
First Decision by Editorial Office Director |
|
2025-01-08 07:00 |
|
Return for Revision |
|
2025-01-08 07:00 |
|
Revised |
|
2025-01-19 05:23 |
|
Publication Fee Transferred |
|
2025-01-27 06:37 |
|
Second Decision by Editor |
|
2025-02-10 10:03 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-03-05 07:27 |
|
Articles in Press |
|
2025-03-05 07:27 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-03-30 08:05 |
|
Publish the Manuscript Online |
|
2025-04-25 07:53 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Immunosuppressive agents in diabetes treatment: Hope or despair?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lu Li, Xi Yang, Jin-Shuai Ren, Ming-Zhu Huang and Qing-Wei Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The National Natural Science Foundation of China |
82273986 |
| Natural Science Foundation of Zhejiang Province |
LYY22H310014 |
|
| Corresponding Author |
Ming-Zhu Huang, PhD, Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. hmzj2002@zju.edu.cn |
| Key Words |
Immunosuppressive agents; Type 1 diabetes; Type 2 diabetes; Insulin resistance; Transplantation |
| Core Tip |
The exploration of immunosuppressive agents for diabetes treatment is gaining attention. Diabetes' complex etiology offers multiple therapeutic targets. These agents regulate the immune system, which plays a crucial role in diabetes pathogenesis. The review examines their potential in type 1 diabetes, type 2 diabetes, and transplantation. The review aims to reveal the potential and limitations of these therapies by summarizing current research on immunosuppressive agents in diabetes treatment and prevention. |
| Publish Date |
2025-04-25 07:53 |
| Citation |
Li L, Yang X, Ren JS, Huang MZ, Zhao QW. Immunosuppressive agents in diabetes treatment: Hope or despair? World J Diabetes 2025; 16(5): 100590 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i5/100590.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i5.100590 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
